Barriers and solutions to stepping down asthma treatment

Nguyen-Ho Lam*

Asthma is a chronic airway disease with two characteristic features: (1) chronic airway inflammation (the most common eosinophilic airway inflammation) and (2) airway hyperresponsiveness (excessive airway constriction by normal triggers) [1]. Management of asthma requires long-term treatment to achieve well-controlled symptoms and prevent the risk of exacerbation in future. Inhaled corticosteroid (ICS) is the mainstay therapy of asthma with strong evidences [2]. Nonetheless it is still the existence of gap in knowledge “what is the most appropriate dose of ICS to treat asthmatic patient?”. 

Keywords:

Published on: Aug 19, 2020 Pages: 13-15

Full Text PDF Full Text HTML DOI: 10.17352/oja.000013
CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat